Jeffrey D. Bradley, MD

Jeffrey D. Bradley, MD, the S. Lee Kling Professor of Radiation Oncology, is honored for efforts to improve the care of cancer patients through precision radiation therapy.

Considered a tremendous patient advocate, he is a world authority on the treatment of patients with thoracic cancer. He is credited with contributing breakthroughs in the use of positron emission tomography (PET) scanning to improve the accuracy of radiation therapy treatment planning and establishing radiation dose and volume parameters in lung cancer management. He also played a key role in bringing the world’s first compact proton beam accelerator to the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. Continuously involved in clinical investigations of advanced radiation therapies, he leads and participates in numerous research efforts aimed at improving the quality of life for patients with lung and esophageal cancers.

Through his expertise and dedication to the smallest details, he inspires trust and confidence in patients, other faculty and staff, his colleagues report. He is the recipient of several awards for teaching excellence and has made it his mission to instill passion for critical thinking while educating trainees on the importance of advocating for each and every patient, young and old. As a result, his influence has impacted the care of patients worldwide, and he has been honored as Teacher of the Year multiple times by the Department of Radiation Oncology.

Bradley received his medical degree from the University of Arkansas for Medical Sciences in Little Rock, Arkansas. He completed a residency in radiation oncology and was selected for an American Society for Therapeutic Radiology and Oncology Research Fellowship at the University of Chicago Medical Center. He joined the faculty at Washington University’s Mallinckrodt Institute of Radiology in 1998 and became director of the S. Lee Kling Center for Proton Therapy in 2008.